Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Clover Health Investments, Corp. CLOV

Set alert

Price alert · CLOV

All alert types
4.31 USD 0.00 -0.01%

As of Nov 3, 9:58 AM ET

Bid
4.30 × 53
Ask
4.31 × 12
4.29 Day range 4.37
1.58 52-week range 5.59
YTD
+83.38%
1 year
+17.11%
Open
4.31
Prev close
4.31
Mkt cap
2.29B
Vol
267.45K
Avg vol
4.22M
EPS
-0.05
P/E
0.00
Div yield
0.00%
More statistics
Low
4.29
High
4.37
Forward P/E
28.73
Beta
2.48
Short ratio
5.73
Inst. own
33.93%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
4.51
200-d avg
3.54
1y target
5.50

15m chart

Chart tools
Interval
1m5m15m30m

Built from the cached five-day intraday bars.

Events in this range
  • Oct 28, 2026Rating: Needham · — → Buy
Signals (22)
NameTimeAgo
SMA: BearishNov 3, 9:55 AM3 minutes ago
SMA: BullishNov 3, 9:40 AM18 minutes ago
SMA: BearishNov 2, 3:40 PM18 hours ago
SMA: BullishNov 2, 2:55 PM19 hours ago
MACD: Buy SignalNov 2, 12:10 PM21 hours ago
SMA: BullishNov 2, 11:55 AM22 hours ago
MACD: Sell SignalNov 2, 10:55 AM23 hours ago
SMA: BearishNov 2, 10:40 AM23 hours ago
SMA: BullishNov 2, 10:25 AM23 hours ago
SMA: BearishNov 2, 9:40 AM1 day ago
SMA: BullishOct 30, 3:55 PM3 days ago
SMA: BullishOct 30, 2:55 PM3 days ago
SMA: BearishOct 30, 2:10 PM3 days ago
MACD: Buy SignalOct 30, 1:10 PM3 days ago
RSI: OversoldOct 30, 12:40 PM3 days ago
RSI: OversoldOct 29, 3:40 PM4 days ago
MACD: Sell SignalOct 29, 2:10 PM4 days ago
MACD: Buy SignalOct 29, 1:25 PM4 days ago
SMA: BullishOct 29, 1:10 PM4 days ago
SMA: BearishOct 29, 9:40 AM5 days ago

Newest 20 of 22.

Analyst view

Consensus: buy

Buy
Price target (mean) 5.50 +27.6% upside
Target (low)
5.00
Target (mean)
5.50
Target (high)
6.00
Ratings (0m) 5 3 buy · 2 hold · 0 sell
  • Strong buy1
  • Buy2
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 4
  • 2 months ago 3

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CLOV analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.010.01 – 0.010.0033+203.0%738.42M+48.7%1
Next quarter-0.02-0.02 – -0.02-0.0459+56.4%723.47M+48.3%1
Current year0.140.14 – 0.140.039+259.0%2.95B+53.5%1
Next year0.150.15 – 0.150.14+7.1%3.54B+19.8%1

Upgrades and downgrades

The latest rating changes

CLOV analyst upgrades and downgrades
DateFirmActionFromTo
Oct 28, 2026NeedhamInitiated—Buy
Aug 6, 2026UBSMaintainedNeutralNeutral
Jul 21, 2026Canaccord GenuityMaintainedBuyBuy
Jun 11, 2026UBSMaintainedNeutralNeutral
Jun 4, 2026Canaccord GenuityMaintainedBuyBuy
Mar 20, 2026Canaccord GenuityMaintainedBuyBuy
Mar 5, 2026Leerink PartnersMaintainedMarket PerformMarket Perform
Jan 20, 2026Canaccord GenuityMaintainedBuyBuy
Nov 6, 2025Canaccord GenuityMaintainedBuyBuy
Aug 7, 2025Canaccord GenuityMaintainedBuyBuy
Aug 6, 2025UBSMaintainedNeutralNeutral
Mar 3, 2025Canaccord GenuityMaintainedBuyBuy
Dec 17, 2024Craig-HallumInitiated—Buy
Oct 7, 2024UBSInitiated—Neutral
Aug 11, 2023CitigroupMaintainedNeutralNeutral
Mar 6, 2023Canaccord GenuityMaintained—Buy
Mar 6, 2023Credit SuisseMaintained—Underperform
Nov 16, 2022CitigroupMaintained—Neutral
Nov 8, 2022SVB LeerinkMaintained—Market Perform
Aug 9, 2022CitigroupMaintained—Neutral
Aug 9, 2022Credit SuisseMaintained—Underperform
May 10, 2022SVB LeerinkMaintained—Market Perform
Feb 25, 2022SVB LeerinkMaintained—Market Perform
Feb 2, 2022Canaccord GenuityInitiated—Buy
Feb 2, 2022Cowen & Co.UpgradeUnderperformMarket Perform
Jan 19, 2022SVB LeerinkInitiated—Market Perform
Jan 7, 2022Credit SuisseDowngradeNeutralUnderperform
Nov 15, 2021Credit SuisseMaintained—Neutral
Sep 10, 2021Cowen & Co.Initiated—Underperform
Jul 12, 2021JP MorganDowngradeNeutralUnderweight